Health ❯ Healthcare
Dementia Psychiatry Depression Emotional Well-being Transgender Health Gender Dysphoria Stress Management Trauma Substance Abuse Patient Care
The result increases doubt over whether the drug can show a replicable benefit in phase‑3 trials.